Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...
GlobalData on MSN10d
Allurion’s weight loss balloon back on French marketAllurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...
Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...
Allurion Technologies today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume ...
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion ...
The Allurion Balloon, a non-surgical gastric balloon for weight loss, has previously shown promise when used in tandem with GLP-1 agonists. A study published in Obesity Surgery revealed that ...
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion ...
The Allurion Balloon, a non-surgical gastric balloon for weight loss, has previously shown promise when used in tandem with GLP-1 agonists. A study published in Obesity Surgery revealed that patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback